{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:00:31Z","timestamp":1793948431349,"version":"4.8.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02705-9","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:29:45Z","timestamp":1745414985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study"],"prefix":"10.1186","volume":"24","clinical-trial-number":[{"clinical-trial-number":"nct02431234","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Damien","family":"Denimal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maharajah","family":"Ponnaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Caroline","family":"Jeannin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Redheuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe-Elie","family":"Salem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Boussouar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Paulstephenraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Laroche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Amouyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Hartemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Foufelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Bourron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"key":"2705_CR1","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.2337\/diacare.26.12.3333","volume":"26","author":"American Diabetes Association","year":"2003","unstructured":"American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333\u201341.","journal-title":"Diabetes Care"},{"key":"2705_CR2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1161\/ATVBAHA.121.316252","volume":"42","author":"HC St","year":"2022","unstructured":"St HC. Medial arterial calcification: a significant and independent contributor of peripheral artery disease. Arterioscler Thromb Vasc Biol. 2022;42:253\u201360.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2705_CR3","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","volume":"144","author":"MH Criqui","year":"2021","unstructured":"Criqui MH, Matsushita K, Aboyans V, Hess CN, Hicks CW, Kwan TW, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American Heart Association. Circulation. 2021;144:e171\u201391.","journal-title":"Circulation"},{"key":"2705_CR4","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.jacc.2007.12.058","volume":"51","author":"RJ Guzman","year":"2008","unstructured":"Guzman RJ, Brinkley DM, Schumacher PM, Donahue RMJ, Beavers H, Qin X. Tibial artery calcification as a marker of amputation risk in patients with peripheral arterial disease. J Am Coll Cardiol. 2008;51:1967\u201374.","journal-title":"J Am Coll Cardiol"},{"key":"2705_CR5","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/BF00279127","volume":"31","author":"JE Everhart","year":"1988","unstructured":"Everhart JE, Pettitt DJ, Knowler WC, Rose FA, Bennett PH. Medial arterial calcification and its association with mortality and complications of diabetes. Diabetologia. 1988;31:16\u201323.","journal-title":"Diabetologia"},{"key":"2705_CR6","doi-asserted-by":"publisher","first-page":"e90201","DOI":"10.1371\/journal.pone.0090201","volume":"9","author":"C-L Huang","year":"2014","unstructured":"Huang C-L, Wu I-H, Wu Y-W, Hwang J-J, Wang S-S, Chen W-J, et al. Association of lower extremity arterial calcification with amputation and mortality in patients with symptomatic peripheral artery disease. PLoS ONE. 2014;9:e90201.","journal-title":"PLoS ONE"},{"key":"2705_CR7","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.jvs.2017.06.086","volume":"67","author":"SL Zettervall","year":"2018","unstructured":"Zettervall SL, Marshall AP, Fleser P, Guzman RJ. Association of arterial calcification with chronic limb ischemia in patients with peripheral artery disease. J Vasc Surg. 2018;67:507\u201313.","journal-title":"J Vasc Surg"},{"key":"2705_CR8","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.jacc.2018.08.002","volume":"72","author":"N Narula","year":"2018","unstructured":"Narula N, Dannenberg AJ, Olin JW, Bhatt DL, Johnson KW, Nadkarni G, et al. Pathology of peripheral artery disease in patients with critical limb ischemia. J Am Coll Cardiol. 2018;72:2152\u201363.","journal-title":"J Am Coll Cardiol"},{"key":"2705_CR9","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1210\/jc.2014-1047","volume":"99","author":"O Bourron","year":"2014","unstructured":"Bourron O, Aubert CE, Liabeuf S, Cluzel P, Lajat-Kiss F, Dadon M, et al. Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor \u03baB ligand, osteoprotegerin, and neuropathy. J Clin Endocrinol Metab. 2014;99:4250\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2705_CR10","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/jcm12041299","volume":"12","author":"T Ohtake","year":"2023","unstructured":"Ohtake T, Mitomo A, Yamano M, Shimizu T, Mochida Y, Ishioka K, et al. Impact of arterial calcification of the lower limbs on long-term clinical outcomes in patients on hemodialysis. J Clin Med. 2023;12:1299.","journal-title":"J Clin Med"},{"key":"2705_CR11","doi-asserted-by":"crossref","unstructured":"Chowdhury MM, Makris GC, Tarkin JM, Joshi FR, Hayes PD, Rudd James HF, et al. Lower limb arterial calcification (LLAC) scores in patients with symptomatic peripheral arterial disease are associated with increased cardiac mortality and morbidity. PLOS ONE. 2017;12:0182952.","DOI":"10.1371\/journal.pone.0182952"},{"key":"2705_CR12","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","volume":"79","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79:1542\u201356.","journal-title":"J Hepatol"},{"key":"2705_CR13","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.2337\/dc22-2048","volume":"46","author":"L Castera","year":"2023","unstructured":"Castera L, Laouenan C, Vallet-Pichard A, Vidal-Tr\u00e9can T, Manchon P, Paradis V, et al. High prevalence of NASH and advanced fibrosis in type 2 diabetes: a prospective study of 330 outpatients undergoing liver biopsies for elevated ALT, using a low threshold. Diabetes Care. 2023;46:1354\u201362.","journal-title":"Diabetes Care"},{"key":"2705_CR14","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1111\/imj.13549","volume":"47","author":"Y Zou","year":"2017","unstructured":"Zou Y, Li X, Wang C, Wang J, Wang F, Ma L, et al. Association between non-alcoholic fatty liver disease and peripheral artery disease in patients with type 2 diabetes. Intern Med J. 2017;47:1147\u201353.","journal-title":"Intern Med J"},{"key":"2705_CR15","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/1753-0407.12441","volume":"9","author":"Y Liu","year":"2017","unstructured":"Liu Y, Liu C, Shi X, Lin M, Yan B, Zeng X, et al. Correlations of non-alcoholic fatty liver disease and serum uric acid with subclinical atherosclerosis in obese Chinese adults. J Diabetes. 2017;9:586\u201395.","journal-title":"J Diabetes"},{"key":"2705_CR16","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2147\/DMSO.S394414","volume":"16","author":"X-H Song","year":"2023","unstructured":"Song X-H, Liu B, Lei F, Liu Y-M, Zhang X, Chen Z, et al. The association between metabolic dysfunction-associated fatty liver disease and peripheral arterial disease in the Chinese population. Diabetes Metab Syndr Obes. 2023;16:373\u201384.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2705_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.31083\/j.rcm2510362","volume":"25","author":"P Mai","year":"2024","unstructured":"Mai P, Li Q, Li S, Wang C, Xu S, Zhang K, et al. The Association between fatty liver index and lower limb arterial calcification in patients with type 2 diabetes mellitus. Rev Cardiovasc Med. 2024;25:362.","journal-title":"Rev Cardiovasc Med"},{"key":"2705_CR18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1046\/j.1464-5491.2002.00698.x","volume":"19","author":"CA Abbott","year":"2002","unstructured":"Abbott CA, Carrington AL, Ashe H, Bath S, Every LC, Griffiths J, et al. The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort. Diabet Med. 2002;19:377\u201384.","journal-title":"Diabet Med"},{"key":"2705_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","volume":"15","author":"AS Agatston","year":"1990","unstructured":"Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"2705_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s12933-020-01122-4","volume":"19","author":"O Bourron","year":"2020","unstructured":"Bourron O, Phan F, Diallo MH, Hajage D, Aubert C-E, Carlier A, et al. Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study. Cardiovasc Diabetol. 2020;19:140.","journal-title":"Cardiovasc Diabetol"},{"key":"2705_CR21","doi-asserted-by":"publisher","first-page":"e30325","DOI":"10.1371\/journal.pone.0030325","volume":"7","author":"T Poynard","year":"2012","unstructured":"Poynard T, Lassailly G, Diaz E, Clement K, Ca\u00efazzo R, Tordjman J, et al. Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data. PLoS ONE. 2012;7:e30325.","journal-title":"PLoS ONE"},{"key":"2705_CR22","doi-asserted-by":"publisher","first-page":"100154","DOI":"10.1016\/j.xcrm.2020.100154","volume":"1","author":"A Carlier","year":"2020","unstructured":"Carlier A, Phan F, Szpigel A, Hajduch E, Salem JE, Gautheron J, et al. Dihydroceramides in triglyceride-enriched VLDL are associated with nonalcoholic fatty liver disease severity in type 2 diabetes. Cell Rep Med. 2020;1:100154.","journal-title":"Cell Rep Med"},{"issue":"39","key":"2705_CR23","first-page":"763","volume":"2018","author":"V Aboyans","year":"2017","unstructured":"Aboyans V, Ricco J-B, Bartelink M-LEL, Bj\u00f6rck M, Brodmann M, Cohnert T, et al. ESC Guidelines on the diagnosis and treatment of peripheral arterial diseases. Eur Heart J. 2017;2018(39):763\u2013816.","journal-title":"Eur Heart J"},{"key":"2705_CR24","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1002\/jcp.30887","volume":"237","author":"K Phadwal","year":"2022","unstructured":"Phadwal K, Koo E, Jones RA, Forsythe RO, Tang K, Tang Q, et al. Metformin protects against vascular calcification through the selective degradation of Runx2 by the p62 autophagy receptor. J Cell Physiol. 2022;237:4303\u201316.","journal-title":"J Cell Physiol"},{"key":"2705_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12933-017-0509-7","volume":"16","author":"A Mary","year":"2017","unstructured":"Mary A, Hartemann A, Liabeuf S, Aubert CE, Kemel S, Salem JE, et al. Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients. Cardiovasc Diabetol. 2017;16:24.","journal-title":"Cardiovasc Diabetol"},{"key":"2705_CR26","doi-asserted-by":"publisher","first-page":"e028985","DOI":"10.1161\/JAHA.122.028985","volume":"12","author":"Z Ke","year":"2023","unstructured":"Ke Z, Huang R, Xu X, Liu W, Wang S, Zhang X, et al. Long-term high level of insulin resistance is associated with an increased prevalence of coronary artery calcification: The CARDIA Study. J Am Heart Assoc. 2023;12:e028985.","journal-title":"J Am Heart Assoc"},{"key":"2705_CR27","doi-asserted-by":"publisher","first-page":"115087","DOI":"10.1016\/j.bone.2019.115087","volume":"130","author":"A El Jamal","year":"2020","unstructured":"El Jamal A, Bougault C, Mebarek S, Magne D, Cuvillier O, Brizuela L. The role of sphingosine 1-phosphate metabolism in bone and joint pathologies and ectopic calcification. Bone. 2020;130:115087.","journal-title":"Bone"},{"key":"2705_CR28","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2337\/dc10-0788","volume":"34","author":"DP Lorant","year":"2011","unstructured":"Lorant DP, Grujicic M, Hoebaus C, Brix J-M, Hoellerl F, Schernthaner G, et al. Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease. Diabetes Care. 2011;34:156\u201361.","journal-title":"Diabetes Care"},{"key":"2705_CR29","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1177\/1358863X20979738","volume":"26","author":"F Losurdo","year":"2021","unstructured":"Losurdo F, Ferraresi R, Ucci A, Zanetti A, Clerici G, Zambon A. Association of infrapopliteal medial arterial calcification with lower-limb amputations in high-risk patients: a systematic review and meta-analysis. Vasc Med. 2021;26:164\u201373.","journal-title":"Vasc Med"},{"key":"2705_CR30","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/hep.26156","volume":"57","author":"D Kim","year":"2013","unstructured":"Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology. 2013;57:1357\u201365.","journal-title":"Hepatology"},{"key":"2705_CR31","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13098-023-01031-y","volume":"15","author":"M Namakchian","year":"2023","unstructured":"Namakchian M, Rabizadeh S, Seifouri S, Asadigandomani H, Bafrani MA, Seifouri K, et al. Fibrosis score 4 index has an independent relationship with coronary artery diseases in patients with metabolic-associated fatty liver disease. Diabetol Metab Syndr. 2023;15:57.","journal-title":"Diabetol Metab Syndr"},{"key":"2705_CR32","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/hep.27368","volume":"61","author":"M Ekstedt","year":"2015","unstructured":"Ekstedt M, Hagstr\u00f6m H, Nasr P, Fredrikson M, St\u00e5l P, Kechagias S, et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61:1547\u201354.","journal-title":"Hepatology"},{"key":"2705_CR33","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.jacc.2016.01.070","volume":"67","author":"I Zeb","year":"2016","unstructured":"Zeb I, Li D, Budoff MJ, Katz R, Lloyd-Jones D, Agatston A, et al. Nonalcoholic fatty liver disease and incident cardiac events. J Am Coll Cardiol. 2016;67:1965\u20136.","journal-title":"J Am Coll Cardiol"},{"key":"2705_CR34","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/apt.12946","volume":"40","author":"H Perazzo","year":"2014","unstructured":"Perazzo H, Munteanu M, Ngo Y, Lebray P, Seurat N, Rutka F, et al. Prognostic value of liver fibrosis and steatosis biomarkers in type 2 diabetes and dyslipidaemia. Aliment Pharmacol Ther. 2014;40:1081\u201393.","journal-title":"Aliment Pharmacol Ther"},{"key":"2705_CR35","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12933-024-02161-x","volume":"23","author":"D Denimal","year":"2024","unstructured":"Denimal D, Ponnaiah M, Jeannin A-C, Phan F, Hartemann A, Boussouar S, et al. Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts. Cardiovasc Diabetol. 2024;23:69.","journal-title":"Cardiovasc Diabetol"},{"key":"2705_CR36","doi-asserted-by":"publisher","first-page":"18323","DOI":"10.1038\/s41598-020-75266-4","volume":"10","author":"J Lee","year":"2020","unstructured":"Lee J, Kim HS, Cho YK, Kim EH, Lee MJ, Bae IY, et al. Association between noninvasive assessment of liver fibrosis and coronary artery calcification progression in patients with nonalcoholic fatty liver disease. Sci Rep. 2020;10:18323.","journal-title":"Sci Rep"},{"key":"2705_CR37","doi-asserted-by":"publisher","first-page":"6564","DOI":"10.1038\/s41598-022-10487-3","volume":"12","author":"CM Perdomo","year":"2022","unstructured":"Perdomo CM, Ezponda A, N\u00fa\u00f1ez-C\u00f3rdoba JM, Herrero JI, Bastarrika G, Fr\u00fchbeck G, et al. Transient elastography and serum markers of liver fibrosis associate with epicardial adipose tissue and coronary artery calcium in NAFLD. Sci Rep. 2022;12:6564.","journal-title":"Sci Rep"},{"key":"2705_CR38","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/apt.16324","volume":"53","author":"JG Park","year":"2021","unstructured":"Park JG, Jung J, Verma KK, Kang MK, Madamba E, Lopez S, et al. Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2021;53:1030\u20137.","journal-title":"Aliment Pharmacol Ther"},{"key":"2705_CR39","first-page":"101586","volume":"15","author":"J-M Davaine","year":"2024","unstructured":"Davaine J-M, Denimal D, Treca P, Francon H, Phan F, Hartemann A, et al. Medial arterial calcification of the lower limbs in diabetes: Time for awareness? A short narrative review. Diabetes Metab. 2024;15:101586.","journal-title":"Diabetes Metab"},{"key":"2705_CR40","doi-asserted-by":"publisher","first-page":"1093355","DOI":"10.3389\/fcvm.2023.1093355","volume":"10","author":"TI Kim","year":"2023","unstructured":"Kim TI, Guzman RJ. Medial artery calcification in peripheral artery disease. Front Cardiovasc Med. 2023;10:1093355.","journal-title":"Front Cardiovasc Med"},{"key":"2705_CR41","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.3390\/ijms21113863","volume":"21","author":"H Fujii","year":"2020","unstructured":"Fujii H, Kawada N. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol Sci. 2020;21:3863.","journal-title":"Int J Mol Sci"},{"key":"2705_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1186\/s12933-023-02049-2","volume":"22","author":"D Denimal","year":"2023","unstructured":"Denimal D, B\u00e9land-Bonenfant S, Pais-de-Barros J-P, Rouland A, Bouillet B, Duvillard L, et al. Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2023;22:310.","journal-title":"Cardiovasc Diabetol"},{"key":"2705_CR43","doi-asserted-by":"publisher","first-page":"e82379","DOI":"10.1371\/journal.pone.0082379","volume":"8","author":"L Liao","year":"2013","unstructured":"Liao L, Zhou Q, Song Y, Wu W, Yu H, Wang S, et al. Ceramide mediates Ox-LDL-induced human vascular smooth muscle cell calcification via p38 mitogen-activated protein kinase signaling. PLoS ONE. 2013;8:e82379.","journal-title":"PLoS ONE"},{"key":"2705_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1194\/jlr.M079731","volume":"59","author":"TG Morris","year":"2018","unstructured":"Morris TG, Borland SJ, Clarke CJ, Wilson C, Hannun YA, Ohanian V, et al. Sphingosine 1-phosphate activation of ERM contributes to vascular calcification. J Lipid Res. 2018;59:69\u201378.","journal-title":"J Lipid Res"},{"key":"2705_CR45","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","volume":"35","author":"N Stefan","year":"2023","unstructured":"Stefan N, Schick F, Birkenfeld AL, H\u00e4ring H-U, White MF. The role of hepatokines in NAFLD. Cell Metab. 2023;35:236\u201352.","journal-title":"Cell Metab"},{"key":"2705_CR46","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1681\/ASN.2008060572","volume":"20","author":"R Westenfeld","year":"2009","unstructured":"Westenfeld R, Sch\u00e4fer C, Kr\u00fcger T, Haarmann C, Schurgers LJ, Reutelingsperger C, et al. Fetuin-A protects against atherosclerotic calcification in CKD. J Am Soc Nephrol. 2009;20:1264\u201374.","journal-title":"J Am Soc Nephrol"},{"key":"2705_CR47","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/apt.16543","volume":"54","author":"T Poynard","year":"2021","unstructured":"Poynard T, Paradis V, Mullaert J, Deckmyn O, Gault N, Marcault E, et al. Prospective external validation of a new non-invasive test for the diagnosis of non-alcoholic steatohepatitis in patients with type 2 diabetes. Aliment Pharmacol Ther. 2021;54:952\u201366.","journal-title":"Aliment Pharmacol Ther"},{"key":"2705_CR48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/jim-2018-000864","volume":"67","author":"F Bril","year":"2019","unstructured":"Bril F, McPhaul MJ, Caulfield MP, Castille J-M, Poynard T, Soldevila-Pico C, et al. Performance of the SteatoTest, ActiTest, NashTest and FibroTest in a multiethnic cohort of patients with type 2 diabetes mellitus. J Investig Med. 2019;67:303\u201311.","journal-title":"J Investig Med"},{"key":"2705_CR49","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/apt.17688","volume":"58","author":"T Poynard","year":"2023","unstructured":"Poynard T, Deckmyn O, Peta V, Paradis V, Gautier J-F, Brzustowski A, et al. Prospective direct comparison of non-invasive liver tests in outpatients with type 2 diabetes using intention-to-diagnose analysis. Aliment Pharmacol Ther. 2023;58:888\u2013902.","journal-title":"Aliment Pharmacol Ther"},{"key":"2705_CR50","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver Clinical Practice Guideline Panel. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis\u20142021 update. J Hepatol. 2021;75:659\u201389.","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"2705_CR51","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD), European Association for the Study of Obesity (EASO). EASL\u2013EASD\u2013EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. Diabetologia. 2016;59:1121\u201340.","DOI":"10.1007\/s00125-016-3902-y"},{"key":"2705_CR52","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1097\/MEG.0000000000001606","volume":"32","author":"T Poynard","year":"2020","unstructured":"Poynard T, Peta V, Deckmyn O, Pais R, Ngo Y, Charlotte F, et al. Performance of liver biomarkers, in patients at risk of nonalcoholic steato-hepatitis, according to presence of type-2 diabetes. Eur J Gastroenterol Hepatol. 2020;32:998\u20131007.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2705_CR53","doi-asserted-by":"crossref","unstructured":"Caussy C, Verg\u00e8s B, Leleu D, Duvillard L, Subtil F, Abichou-Klich A, et al. Screening for metabolic dysfunction-associated steatotic liver disease-related advanced fibrosis in Diabetology: A Prospective Multicenter Study. Diabetes Care. 2025;dc242075.","DOI":"10.2337\/dc24-2075"},{"key":"2705_CR54","doi-asserted-by":"publisher","first-page":"327","DOI":"10.2337\/cd21-0104","volume":"40","author":"A Meritsi","year":"2022","unstructured":"Meritsi A, Latsou D, Manesis E, Gatos I, Theotokas I, Zoumpoulis P, et al. Noninvasive, blood-based biomarkers as screening tools for hepatic fibrosis in people with type 2 diabetes. Clin Diabetes. 2022;40:327\u201338.","journal-title":"Clin Diabetes"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02705-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02705-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02705-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:03:46Z","timestamp":1745420626000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02705-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2705"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02705-9","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study involving human participants have been performed in accordance with the Declaration of Helsinki and have been approved by our local ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}